Drug Information

General Information
Drug ID
DR01170
Drug Name
Toremifene
Synonyms
(Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; 2-(p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]-phenoxy)-N,N-dimethyl-ethylamine citrate(1:1); 2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine (IUPAC); 2-({4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenyl}oxy)-N,N-dimethylethanamine; 2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; Acapodene; Acapodene (TN); Estrimex; FC-1157a; Fareston (TN); Farestone; GTX-006 (Acapodene); GTx 006; GTx-006; Toremifene (INN); Toremifene Base; Toremifene Citrate (1:1); Toremifene [INN:BAN]; Toremifeno; Toremifeno [Spanish]; Toremifenum; Toremifenum [Latin]; Z-Toremifene; {2-[4-(4-Chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-dimethyl-amine
Drug Type
Small molecular drug
Indication Breast cancer [ICD11: 2C60-2C6Z] Approved [1]
Therapeutic Class
Anticancer Agents
Structure
3D MOL 2D MOL
Formula
C26H28ClNO
Canonical SMILES
CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChI=1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3/b26-25-
InChIKey
XFCLJVABOIYOMF-QPLCGJKRSA-N
CAS Number
CAS 89778-26-7
Pharmaceutical Properties Molecular Weight 406 Topological Polar Surface Area 12.5
Heavy Atom Count 29 Rotatable Bond Count 9
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 2
XLogP
7.2
PubChem CID
3005573
PubChem SID
10038137 , 103628891 , 10366 , 111617870 , 11528602 , 117870220 , 12013627 , 124892293 , 126621304 , 126648750 , 126669839 , 127316634 , 127316635 , 127316636 , 127316637 , 127316638 , 127316639 , 127316640 , 127316641 , 127316642 , 127316643 , 127316644 , 127316645 , 127316646 , 127316647 , 127316648 , 127316649 , 127316650 , 127316651 , 127316652 , 127316653 , 127316654 , 127316655 , 14757386 , 29216214 , 36055011 , 46506087 , 48416648 , 53787422 , 56352877 , 57410179 , 76883860 , 7980819 , 92309038 , 92718822 , 93165674 , 93166369 , 93167220 , 93626357 , 96025304
ChEBI ID
ChEBI:9635
TTD Drug ID
D04VFJ
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Toremifene was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Antiestrogens and steroid hormones: substrates of the human P-glycoprotein. Biochem Pharmacol. 1994 Jul 19;48(2):287-92.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.